As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

A next-generation Novo Nordisk obesity drug designed to hit two targets has preliminary clinical data showing 22% weight loss, results that suggest the once-weekly injection could have an edge ...